FDAnews
www.fdanews.com/articles/127002-strides-gets-fda-nod-for-marketing-bacitracin-injections-in-us

Strides Gets FDA Nod for Marketing Bacitracin Injections in US

May 12, 2010
Drug firm Strides Acrolab Wednesday said that it has received the FDA nod for marketing and distributing Bacitracin injections, an anti-infective used to treat pneumonia, in the US.
Business Standard